Circulating tumor cells in precision medicine: challenges and opportunities

Brittany Rupp¹, Harrison Ball¹, Fulei Wuchu², Deepak Nagrath³, Sunitha Nagrath⁴

Affiliations

¹ Department of Chemical Engineering, University of Michigan, Ann Arbor, MI, 48109, USA; Biointerfaces Institute, University of Michigan, Ann Arbor, MI, 48109,USA.
² Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA.
³ Biointerfaces Institute, University of Michigan, Ann Arbor, MI, 48109,USA; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA; Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: dnagrath@umich.edu.
⁴ Department of Chemical Engineering, University of Michigan, Ann Arbor, MI, 48109, USA; Biointerfaces Institute, University of Michigan, Ann Arbor, MI, 48109,USA; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA; Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: snagrath@umich.edu.

PMID: 35272862
DOI: 10.1016/j.tips.2022.02.005

Review

Circulating tumor cells in precision medicine: challenges and opportunities

Brittany Rupp et al. Trends Pharmacol Sci. 2022 May.

. 2022 May;43(5):378-391.

doi: 10.1016/j.tips.2022.02.005. Epub 2022 Mar 7.

Authors

Brittany Rupp¹, Harrison Ball¹, Fulei Wuchu², Deepak Nagrath³, Sunitha Nagrath⁴

Affiliations

¹ Department of Chemical Engineering, University of Michigan, Ann Arbor, MI, 48109, USA; Biointerfaces Institute, University of Michigan, Ann Arbor, MI, 48109,USA.
² Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA.
³ Biointerfaces Institute, University of Michigan, Ann Arbor, MI, 48109,USA; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA; Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: dnagrath@umich.edu.
⁴ Department of Chemical Engineering, University of Michigan, Ann Arbor, MI, 48109, USA; Biointerfaces Institute, University of Michigan, Ann Arbor, MI, 48109,USA; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA; Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: snagrath@umich.edu.

PMID: 35272862
DOI: 10.1016/j.tips.2022.02.005

Abstract

The mutational and phenotypic landscape of tumors is dynamic, requiring constant monitoring of cancer patients to provide the most up-to-date and effective care. Circulating tumor cells (CTCs) obtained via liquid biopsy can provide tumor DNA, RNA, and protein information that can aid in the diagnosis, prognosis, and treatment of patients. There have been many recent studies and advances in using CTC enumeration, characterization, and expansion to provide personalized cancer treatment, validating the benefit of using CTCs as a biomarker in standard of care procedures. In this paper, we aim to summarize these advances, their limitations, and suggest future areas of study necessary to bring CTC analysis to clinics.

Keywords: circulating tumor cells; liquid biopsy; organoids; personalized medicine; single cell analysis.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests S.N. is one of the named inventors on a patent for Microfluidic Labyrinth Technology granted to the University of Michigan. S.N is the co-founder of Labyrinth Biotech Inc. The funders and the company had no role/influence in the views expressed in this article or in the writing of the manuscript

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

R01 CA208335/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Circulating tumor cells in precision medicine: challenges and opportunities

Affiliations

Circulating tumor cells in precision medicine: challenges and opportunities

Authors

Affiliations

Abstract

Conflict of interest statement

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources